Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

COVID-19 and immunodeficiency

COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a highly infectious disease. As of today, over 170,000 people worldwide have succumbed to the infection. Reports have shown that some comorbidities and illnesses raise the risk of getting infected and also influence the severity of the disease. Having a compromised immune system can also drastically raise the risk of getting COVID-19.

21 Apr 2020

Novel 3D fusion imaging improves diagnosis of coronary artery disease

Coronary artery disease is the most common type of heart disease, according to the Centers for Disease Control and Prevention. About 18.2 million adults in the United States have coronary artery disease.

16 Apr 2020

3D fusion imaging improves coronary artery disease diagnosis

Researchers have overcome limitations of combining CT and MRI with a 3D imaging method for diagnosing coronary artery disease.

16 Apr 2020

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

Type 2 diabetes affects treatment options for patients who have both coronary artery disease and T2D, according to a new American Heart Association Scientific Statement, published today in the Association's flagship journal Circulation.

13 Apr 2020

People with type 2 diabetes and heart disease may benefit from newer therapies

Type 2 diabetes (T2D) may affect treatment options for patients who have both coronary artery disease (CAD) and T2D.

13 Apr 2020

New guidance on treating COVID-19 patients with heart attack signs

Much remains unknown about COVID-19, but many studies already have indicated that people with cardiovascular disease are at greater risk of COVID-19.

9 Apr 2020

CVIA publishes new issue that brings key research papers from top cardiologists

The journal Cardiovascular Innovations and Applications (CVIA) has just published a new issue, Volume 4 Issue 3 with an invitation to join the International Brugada Electrocardiographic Indices Registry.

1 Apr 2020

Evinacumab drug reduces cholesterol levels in patients with rare cholesterol disorder

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled trial of the drug, which is being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

31 Mar 2020

Higher serum EPA levels from prescription fish oil associated with lower cardiovascular events

Higher levels of the omega-3 fatty acid eicosapentaenoic acid (EPA) found in the blood—and not a decrease in triglyceride levels as originally thought—appear to explain the striking reductions in cardiovascular events and deaths seen among people taking 4 grams daily of the prescription fish oil, icosapent ethyl, according to findings from a REDUCE-IT substudy presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology

30 Mar 2020

Patients with chest pain, abnormal stress test results need attention even if arteries are clear

Patients who experience chest pain and have abnormal results on a cardiac stress test but who do not have blocked arteries often experience changes in their symptoms and stress test results over time, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

30 Mar 2020

Monoclonal antibody reduces LDL cholesterol in adult patients with HoFH

The cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous familial hypercholesterolemia (HoFH), according to a phase three clinical trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

30 Mar 2020

Taking ticagrelor alone better for patients with complex heart disease

Patients with complex heart disease who stopped taking aspirin three months after the insertion of one or more coronary stents and then took the anti-platelet medication ticagrelor alone for a year had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both aspirin and ticagrelor over the same period.

30 Mar 2020

10-year follow-up study shows safety, efficacy of stenting compared with bypass surgery

In a study with the longest follow-up to date of patients with a high-risk form of heart disease known as left main coronary artery disease (LMCAD), researchers found no significant differences in rates of death, heart attack or stroke between patients who were treated with a stent and those who underwent heart bypass surgery.

30 Mar 2020

Low-dose rivaroxaban reduces adverse heart events in symptomatic PAD post-intervention

People with symptomatic peripheral artery disease who took the blood thinner rivaroxaban with aspirin after undergoing a procedure to treat blocked arteries in the leg (lower extremity revascularization) had a 15% reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

30 Mar 2020

What happens when COVID-19 and cardiovascular diseases mix?

The world has been brought to a stand-still by the COVID-19 pandemic that has affected 197 countries, areas and territories, infected 467,594, and killed 21,181 individuals as of today. COVID-19 disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a single-stranded RNA virus, contagious in humans.

25 Mar 2020

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

James Diaz, MD, MHA, MPH & TM, Dr PH, Professor and Head of Environmental Health Sciences at LSU Health New Orleans School of Public Health, has proposed a possible explanation for the severe lung complications being seen in some people diagnosed with COVID-19.

23 Mar 2020

Women experience more chest pain, but lesser artery narrowing than men

Women with coronary artery disease that reduces blood flow and oxygen to the heart muscle (ischemia) have significantly more chest pain caused by plaque build-up, yet less extensive disease as compared with men, according to new research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

18 Mar 2020

Shorter and longer sleep duration may affect your cardiovascular health

Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.

18 Mar 2020

Sleep duration appears to influence vascular and heart health, experts warn

The amount of sleep a person gets seems to play a defining role in their vascular and heart health.

18 Mar 2020

Social determinants of health offer valuable information about a person's heart disease risk

Certain markers of a person's financial and social status, known as social determinants of health, offer valuable information about a person's potential risk of heart disease but are often overlooked, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

18 Mar 2020

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

COVID-19 and immunodeficiency

Novel 3D fusion imaging improves diagnosis of coronary artery disease

3D fusion imaging improves coronary artery disease diagnosis

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

People with type 2 diabetes and heart disease may benefit from newer therapies

New guidance on treating COVID-19 patients with heart attack signs

CVIA publishes new issue that brings key research papers from top cardiologists

Evinacumab drug reduces cholesterol levels in patients with rare cholesterol disorder

Higher serum EPA levels from prescription fish oil associated with lower cardiovascular events

Patients with chest pain, abnormal stress test results need attention even if arteries are clear

Monoclonal antibody reduces LDL cholesterol in adult patients with HoFH

Taking ticagrelor alone better for patients with complex heart disease

10-year follow-up study shows safety, efficacy of stenting compared with bypass surgery

Low-dose rivaroxaban reduces adverse heart events in symptomatic PAD post-intervention

What happens when COVID-19 and cardiovascular diseases mix?

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

Women experience more chest pain, but lesser artery narrowing than men

Shorter and longer sleep duration may affect your cardiovascular health

Sleep duration appears to influence vascular and heart health, experts warn

Social determinants of health offer valuable information about a person's heart disease risk

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in